欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号IE/H/0753/002
药品名称Gemcitabine
活性成分
    • gemcitabine hydrochloride 200.0 mg/vial
剂型Powder for injection*
上市许可持有人Accord Healthcare Limited Sage House 319 Pinner Road, North Harrow, Middlesex, HA1 4HF
参考成员国 - 产品名称Ireland (IE)
互认成员国 - 产品名称
    • Denmark (DK)
    • Sweden (SE)
    • Greece (GR)
    • Cyprus (CY)
      GEMCITABINE 200mgPWD FOR SOL FOR INF
    • Slovakia (SK)
    • United Kingdom (Northern Ireland) (XI)
    • Spain (ES)
    • Portugal (PT)
    • Norway (NO)
    • Poland (PL)
      Gemcitabine Accord
    • Lithuania (LT)
      Gemcitabine Accord 1000 mg milteliai infuziniam tirpalui
    • Hungary (HU)
      GEMCITABINE ACCORD 1 g por oldatos infúzióhoz
许可日期2009/07/20
最近更新日期2024/03/22
药物ATC编码
    • L01BC05 gemcitabine
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:[not specified]
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase